RAG-17, an experimental RNA-targeting therapy designed to treat amyotrophic lateral sclerosis (ALS) caused by mutations in the SOD1 gene, was…
Articles by Marisa Horak, MS
A feature documentary airing on PBS delves into a man’s final years living with amyotrophic lateral sclerosis (ALS), offering…
Targeting a specific part of the TDP-43 protein can prevent toxic protein clumping that drives amyotrophic lateral sclerosis (ALS)…
A new wearable soft-glove device has successfully restored hand function in a man with amyotrophic lateral sclerosis (ALS), allowing…
Neuralink, a company developing brain-computer interface (BCI) devices aimed at restoring independence to people with paralysis caused by conditions…
The statistical methods scientists use to analyze outcomes from clinical trials in…
Two leaders at Brainstorm Cell Therapeutics, which is developing the experimental cell-based therapy NurOwn (debamestrocel) for people with…
Several nonprofits are uniting to fund new research aimed at identifying targets for the treatment of amyotrophic lateral sclerosis…
Regulatory authorities in the Netherlands have given the green light for a clinical trial testing Ability Neurotech‘s experimental brain-implantable…
Tomorrow, June 2, is Lou Gehrig Day, an annual event that honors the life and legacy of Lou Gehrig, the…